Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients.
ERJ Open Res
; 5(2)2019 Apr.
Article
in En
| MEDLINE
| ID: mdl-31024964
Circulating MFAP4 is a relevant biomarker to identify COPD patients at risk of death and cardiovascular comorbidity after smoking cessation http://ow.ly/6vnL30o8t1g.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
ERJ Open Res
Year:
2019
Document type:
Article
Affiliation country:
Country of publication: